Pfizer to join science circle at Trinity College Dublin Science Gallery

Pfizer (Ireland) announces that it is joining the prestigious Science Circle at the Science Gallery, Trinity College Dublin.

Pfizer to join science circle at Trinity College Dublin Science Gallery

Tuesday 20th November 2012 - Pfizer (Ireland) announces today that it is joining the prestigious Science Circle at the Science Gallery, Trinity College Dublin. Pfizer will be joining other leading global companies in supporting the Science Gallery yearly programmes and fostering the development of science in Ireland.

Dr. Paul Duffy, Vice-President, Pfizer commented on the announcement saying: “Working more closely with academia and third-level graduates in science, particularly chemistry and engineering is key to advancing pharmaceutical manufacturing in Ireland. We invest $7 billion annually in R&D and collaboration is fundamental to our strategy. We see the value in fostering relationships between industry and academia by working with more than 250 academic partners globally. In Ireland we work closely with academia through state-funded initiatives such as the Solid State Pharmaceutical Cluster in UL, we also have close ties to UCC.”

Minister Deenihan said "Today's announcement again shows that the Science Gallery is fast becoming a leader in demonstrating how a major cultural institution can harness both State and private sector Philanthropic support. The Science Circle is a group of companies who commit to an ongoing philanthropic relationship with the Science Gallery over a number of years. The Science Circle is the highest level of commitment to Science Gallery, and I want to pay tribute to Pfizer for making this commitment to the gallery."

“Ireland is a key country within Pfizer and our operations here are extensive. Sites in Ireland are responsible for the global manufacture of many of Pfizer’s leading medicines. Furthermore, five of Pfizer’s newest medicines in cancer, osteoporosis and arthritis are being manufactured from our sites in Ireland,” Dr. Duffy added. “This is testimony not only to the quality and commitment of Pfizer colleagues, but to the excellent graduates we have in Ireland across science, maths and engineering and a deep expertise developed over decades in pharmaceutical manufacturing and technology. Our Process Development Centre (PDC) has been responsible for transformative process innovation fundamentally changing how we manufacture our medicines.”

Welcoming Pfizer into the Science Circle, Founding Director, Michael John Gorman said: “Science Gallery is dedicated to delivering a dynamic and vibrant cultural space and this would not be possible without the support of our Science Circle members. Pfizer is one of the world’s leading pharmaceutical companies working at the cutting edge of scientific advance and innovation. With extensive operations in Ireland, this is a fantastic opportunity to forge stronger links between academia and real-world science application.”

Science Circle at the Science Gallery is a group of leading global companies that are innovators in science and technology with a keen interest in public engagement in science. Their support on a multi-annual basis, allows Science Gallery to invest in its rolling exhibition and events programme that attracts over 250,000 visitors each year.

 

Dr. Paul Duffy, Vice-President, Pfizer and Aoibhinn Ni Shuilleabhain at the Science Circle at the Science Gallery, Trinity College Dublin
Dr. Paul Duffy, Vice-President, Pfizer and Aoibhinn Ni Shuilleabhain at the Science Circle at the Science Gallery, Trinity College Dublin
Aoibhinn Ni Shuilleabhain and Dr. Paul Duffy, Vice-President, Pfizer at the Science Circle at the Science Gallery, Trinity College Dublin
Aoibhinn Ni Shuilleabhain and Dr. Paul Duffy, Vice-President, Pfizer at the Science Circle at the Science Gallery, Trinity College Dublin

Published: 20th November 2012.


« Return to the News section